Tóm tắt
Nghiên cứu giá trị tiên lượng tử vong của NT-proBNP ở bệnh nhân hội chứng mạch vành cấp
Trang chủ
NGHIÊN CỨU LÂM SÀNG
Số phát hành:
Nghiên cứu giá trị tiên lượng tử vong của NT-proBNP ở bệnh nhân hội chứng mạch vành cấp
Nguyễn Thị Thu Phượng: Phòng Y khoa VPĐD Astrazeneca tại Việt Nam;
Hồ Huỳnh Quang Trí: Viện Tim TP. Hồ Chí Minh;
Xuất bản: tháng 7 1, 2015
Views: 3
Tài liệu tham khảo
1.
1. Steg PG, James SK, Atar d, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J doi:10.1093/eurheartj/ehs215.
2.
2. Hamm CW, bassand JP, Agewall S, et al. ESC guidelines for the management of acute coro- nary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the
3.
management of acute coronary syndromes in patients presenting without persistent ST-segment eleva- tion of the European Society of Cardiology. Eur Heart J doi:10.1093/eurheartj/ehr236.
4.
3. O’Gara PT, Kushner FG, Ascheim dd, et al. 2013 ACCF/AHA guideline for the manage- ment of ST-elevation myocardial infarction. A report of the American College of Cardiology Founda- tion/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2013;61:e78-140.
5.
4. Amsterdam EA, Wenger NK, brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes. A report of the American College of Cardiol- ogy/American Heart Association Task Force on practice guidelines. Circulation 2014;130:e344-426.
6.
5. Heeschen C, Hamm CW, Mitrovic v, et al. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004;110:3206-3212.
7.
6. Jernberg T, Stridsberg M, venge P, Lindahl b. N-terminal pro-brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 2002;40:437-445.
8.
7. bjorklund E, Jernberg T, Johanson P, et al. Admission N-terminal probrain natriuretic pep- tide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction. Heart 2006;92:735-740.
9.
8. Morrow dA, Antman EM, Charlesworth A, et al. TiMi risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardial early ii trial substudy. Circulation 2000;102:2031-2037.
10.
9. braunwald E, Cannon CP. Unstable angina and non ST-segment elevation myocardial infarc- tion. Braunwald’s heart disease, 13th edition, 2011:p.1178.
11.
10. James SK, Lindahl b, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)-iV. Circulation 2003;108:275-281.
12.
11. Galvani M, Ottani F, Oltrona L, et al. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation 2004;110:128-134.
13.
12. bazzino O, Fuselli J, bottoc F, et al. Relative value of N-terminal probrain natriuretic peptide, TiMi risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST- elevation acute coronary syndromes. Eur Heart J 2004;25:859-866.